# Top 50 Biotechnology VC (Venture Capital) Funds in Asia in June 2026

## Qiming Venture Partners
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 58
- Stages: Series B, Series A, Series C
- Focus: Health Care, Biotechnology, Medical

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

## HSG
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 43
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Software

We help founders build enduring companies.

## BioVenture
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 33
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

## Lilly Asia Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 30
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. 

## Med-Fine Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 28
- Stages: Series A, Seed, Series B
- Focus: Medical, Health Care, Biotechnology

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

## Kaitai Capital
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 26
- Stages: Series A, Series B, Angel
- Focus: Biotechnology, Health Care, Pharmaceutical

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

## Frees Fund
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 25
- Stages: Series A, Seed, Angel
- Focus: Artificial Intelligence, Health Care, Biotechnology

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

## Matrix Partners China
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 25
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Software

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

## IDG Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 22
- Stages: Series A, Series B, Series C
- Focus: Software, Internet, E-Commerce

IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.

## Sherpa Healthcare Partners
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 22
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships,  as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

## Seeds Capital
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 21
- Stages: Seed, Series A, Series B
- Focus: Software, Biotechnology, Health Care

Catalysing smart monies into Singapore-based, early-stage technology startups.

## Legend Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 19
- Stages: Series B, Series A, Series C
- Focus: Health Care, Medical, Biotechnology

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

## Northern Light Venture Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 19
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

## TF Capital
- Type: VC Fund
- Location: Pudong, Shandong, China
- Relevant deals: 18
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.

## CDH Investments
- Type: VC Fund
- Location: Kowloon City, Kowloon, Hong Kong
- Relevant deals: 18
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Health Care, Biotechnology

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

## Mitsubishi UFJ Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 18
- Stages: Series A, Series B
- Focus: Information Technology, Software, Health Care

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

## Hillhouse Investment
- Type: VC Fund
- Location: Changyang, Beijing, China
- Relevant deals: 18
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Software

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

## UntroD Capital
- Type: VC Fund
- Location: Sumida, Tokyo, Japan
- Relevant deals: 18
- Stages: Seed, Series A
- Focus: Manufacturing, Biotechnology, Medical

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

## Fast Track Initiative, Inc.
- Type: VC Fund
- Location: Hongo, Tokyo, Japan
- Relevant deals: 16
- Stages: Series A, Seed, Series B
- Focus: Health Care, Biotechnology, Medical

Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.

## Highlight Capital
- Type: VC Fund
- Location: Nanjin, Jiangsu, China
- Relevant deals: 16
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Biotechnology

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

## Linear Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 16
- Stages: Seed, Angel, Series A
- Focus: Artificial Intelligence, Software, Manufacturing

Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.

## CD Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 15
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical Device

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

## Osaka University Venture Capital
- Type: VC Fund
- Location: Osaka, Osaka, Japan
- Relevant deals: 15
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Manufacturing

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology.

The firm was founded in 2014 and based in Osaka, Japan.

## ANRI
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 15
- Stages: Seed, Series A
- Focus: Software, Health Care, Information Technology

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

## Puhua Capital
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 15
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Manufacturing

Puhua Capital is an equity investment firm that focuses on early and middle project.

Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

## Delian Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 15
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Manufacturing, Health Care

Founded in 2011, Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare. Their  investments range from robotics, Smart  manufacturing Semiconductor, AI, big data, enterpriseservices, healthcare, etc.Examples of their investment portfolio: YueBoo、Hunan zhongli、Esafenet、Venus MedTech、MicuRx、Rokae、 IMI、12 Sigma Technologies.

## Baidu Ventures
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 14
- Stages: Series A, Seed, Series B
- Focus: Artificial Intelligence, Health Care, Biotechnology

Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains

## Prox Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 14
- Stages: Seed, Series A
- Focus: Medical, Biotechnology, Health Care

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

## Cowin Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 14
- Stages: Series A, Series B, Seed
- Focus: Manufacturing, Health Care, Biotechnology

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

## SMBC Venture Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 14
- Stages: Series A, Series B
- Focus: Information Technology, Health Care, Software

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

## Green Pine Capital Partners
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 14
- Stages: Series A, Series B, Angel
- Focus: Biotechnology, Software, Manufacturing

Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into  388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.

## Gaorong Capital
- Type: VC Fund
- Location: Wangjing, Beijing, China
- Relevant deals: 14
- Stages: Series A, Series B, Seed
- Focus: Information Technology, Software, Artificial Intelligence

Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.

## SDIC Venture Capital
- Type: VC Fund
- Location: Xicheng, Hebei, China
- Relevant deals: 13
- Stages: Series B, Series A, Series C
- Focus: Manufacturing, Biotechnology, Electronics

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion.SDICVC puts into practice the marketization and industrializationof the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully  implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.

## UTEC - The University of Tokyo Edge Capital Partners
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 13
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Medical

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

## BioTrack Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 13
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Medical

BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.

## K2VC
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 12
- Stages: Series A, Seed, Angel
- Focus: E-Commerce, Manufacturing, Biotechnology

K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.

## Legend Star
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 12
- Stages: Series A, Seed, Angel
- Focus: Health Care, Medical, Biotechnology

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

## Cowin Venture
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 12
- Stages: Series A, Angel, Series B
- Focus: Health Care, Medical, Biotechnology

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

## Shenzhen Capital Group
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 12
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Health Care, Software

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB.
SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

## Keio Innovation Initiative
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 12
- Stages: Series A, Seed
- Focus: Health Care, Medical, Biotechnology

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

## Pan-Lin Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 11
- Stages: Series A, Seed, Series B
- Focus: Health Care, Biotechnology, Medical

Panlin Capital, following the investment theme of ‘consumption upgrade driven by  technology innovation’, targets the start-ups which are specialized in biotechnology and data intelligence sectors.As a venture capital corporation, Panlin Capital has became professional as well as influential in the biotechnology and data intelligence sectors.Identify the entrepreneurs among scientists.Enable the innovators among entrepreneurs。

## ZhenFund
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 11
- Stages: Series A, Seed, Angel
- Focus: Artificial Intelligence, Software, E-Commerce

ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.

## LYFE Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 11
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

LYFE Capital is a pure play healthcare focused investment firm.  We believe that “Healthcare has no boundaries”, and that every new choice we made has the potential to advance healthcare and solve the unmet needs for everyone. LYFE Capital operates 5 global offices including our US headquarters in Menlo Park, California, our Asia headquarters inSingapore, as well as locations in Seoul, Tokyo and Shanghai. We leverage our expertise and global resources to invest in and create value for healthcare companies across the globe.  LYFE Capital’s investments span medical devices, therapeutics, diagnostics, and emerging sectors across North America and Asia.

## Addor Capital
- Type: VC Fund
- Location: Nanjing, Jiangsu, China
- Relevant deals: 11
- Stages: Series A, Series B
- Focus: Manufacturing, Semiconductor, Electronics

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

## JAFCO
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 11
- Stages: Series A, Series B
- Focus: Information Technology, Software, Artificial Intelligence

Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.

## Hillhouse Ventures
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 11
- Stages: Series A, Series B, Seed
- Focus: Manufacturing, Biotechnology, Health Care

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

## Shunwei Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 11
- Stages: Series A, Series B, Series C
- Focus: Manufacturing, Software, Internet

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

## Oriental Fortune Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 11
- Stages: Series A, Series B, Seed
- Focus: Software, Manufacturing, Information Technology

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

## Sinovation Ventures
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 10
- Stages: Series A, Seed, Series B
- Focus: Software, Artificial Intelligence, Internet

Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.

## ARCH Venture Partners
- Type: VC Fund
- Location: Chicago, Illinois, United States
- Relevant deals: 10
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences